Insider · CIK 0002000393
Audet Juliette Berangere
Reports to the SEC for 1 company · NAARDEN, P7
Transactions
5
Companies
1
Filings
5
CIK
0002000393
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-05-01 | NAMSNewAmsterdam Pharma Co N.V. · Option (right to buy)A Award | — |
| 2025-01-07 | NAMSNewAmsterdam Pharma Co N.V.A Award | — |
| 2025-01-02 | NAMSNewAmsterdam Pharma Co N.V. · Option (right to buy)A Award | — |
| 2024-09-26 | NAMSNewAmsterdam Pharma Co N.V.P Purchase | +$17.3K |
| 2024-04-01 | NAMSNewAmsterdam Pharma Co N.V. · Option (right to buy)A Award | — |
Recent filings
- 4Audet Juliette Berangere0000950170-25-062897SEC(opens sec.gov)
- 4Audet Juliette Berangere0000950170-25-002996SEC(opens sec.gov)
- 4Audet Juliette Berangere0000950170-25-002370SEC(opens sec.gov)
- 4Audet Juliette Berangere0000950170-24-110440SEC(opens sec.gov)
- 4Audet Juliette Berangere0000950170-24-040235SEC(opens sec.gov)
Companies
Address
C/O NEWAMSTERDAM PHARMA COMPANY N.V. GOOIMEER 2-35
NAARDEN, P7, 1411 DC